Publishing research using ab93739? Please let us know so that we can cite the reference in this datasheet.
ab93739 has been referenced in 4 publications.
Hayes DA et al.ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).PLoS One 12:e0177919 (2017).
Jardé T et al.ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.PLoS One 10:e0138336 (2015).
Lédel F et al.HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.Eur J Cancer N/A:N/A (2013).
Huang J et al.The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells.Mol Cancer 12:134 (2013).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up